Tag: J&ampJ

J&J earnings beat by $0.07, revenue fell short of estimates

 stock analyst  04/16/2024  0 Comments on J&J earnings beat by $0.07, revenue fell short of estimates

Investing.com – J&J (NYSE: JNJ) reported first quarter EPS of $2.71, $0.07 better than the analyst estimate of $2.64. Revenue for the quarter came in at $21.38B versus the consensus estimate of $21.4B.

 Posted in: u.s. stock market today  Tagged: , , , , , , , , , ,

J&J first-quarter revenue misses as Stelara sales disappoint

 stock analyst  04/16/2024  0 Comments on J&J first-quarter revenue misses as Stelara sales disappoint

(Reuters) -Johnson & Johnson reported quarterly revenue below analysts\’ estimates as sales from its blockbuster psoriasis drug Stelara, which is expected to face competition from biosimilar versions in some markets later this year, fell short of expectations.

 Posted in: u.s. stock market today  Tagged: , , , , , , , , ,